United States of America, ex rel, John Doe v. Lincare Holdings, Inc.
Filing
30
ORDER granting in part and denying in part 15 Motion to Dismiss. IT IS HEREBY ORDERED AND ADJUDGED that Count I of Relator's complaint is dismissed without prejudice. FURTHER ORDERED that Relator shall identify himself through an amended complaint within ten (10) days of the entry of this Order. Signed by Honorable David C. Bramlette, III on 2/27/2017 (EB)
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF MISSISSIPPI
WESTERN DIVISION
UNITED STATES OF AMERICA,
ex rel. JOHN DOE
PLAINTIFF
v.
CIVIL ACTION NO. 5:15-cv-19-DCB-MTP
LINCARE HOLDINGS, INC.
DEFENDANT
MEMORANDUM OPINION AND ORDER
This cause is before the Court on defendant Lincare Holdings,
Inc.’s Motion to Dismiss (docket entry 15).
Having carefully
considered the motion, response, and applicable law, and being
otherwise fully informed in the premises, the Court finds as
follows:
I. Facts and Procedural History
Relator John Doe (“Relator”), on behalf of the United States,
filed this qui tam suit against defendant Lincare Holdings, Inc.
(“Lincare”) under the federal False Claims Act (“FCA"), 31 U.S.C.
§§ 3729, et. seq.
Lincare is a national respiratory care provider
with over 1,100 locations across the country. Compl., ¶ 4. Relator
was employed as a salesperson for Lincare, Inc., a wholly-owned
subsidiary of the defendant, from April to September of 2014 in
its Natchez, Mississippi office. Id. at ¶ 2.
Over 80 percent of Lincare’s customers are covered by Medicare
or
Medicaid.
Id.
at
¶
4.
Medicare
includes
a
voluntary
supplemental insurance benefit under “Part B,” which covers the
1
rental of durable medical equipment and other medical supplies.
Id. at 11.
To qualify for Medicare funding, the durable medical
equipment must be medically necessary. Id. at 14.
For a patient
to be medically qualified, the patient must suffer from a severe
lung disease or hypoxia-related symptoms which might be expected
to improve with oxygen therapy, and (among other factors) the
patient must have an arterial oxygen saturation level at or below
88% for at least five minutes. Id. at 19.
Virtuox machines are
generally used to measure patients’ arterial oxygen saturation
level by performing an overnight pulse oximetry test. Id.
Lincare
provides Virtuox machines to potential customers, the customers
use the machine to perform an overnight oximetry test, and Lincare
records the test results and retrieves the Virtuox machine the
following day. Id.
If a patient is otherwise medically qualified
and the Virtuox machine generates a qualifying arterial oxygen
saturation
level,
the
patient’s
physician
then
submits
a
certificate of medical necessity and an order for oxygen supplies.
Id.
Once these steps are completed, providers, like Lincare, may
sell the patient Medicare-covered oxygen supplies. Id.
According to Relator, “Lincare implemented a scheme through
which it falsifie[d] and manipulate[d] its Virtuox testing to
ensure that the results of its tests indicate[d] an arterial oxygen
saturation level at or below 88%.” Id. at 21.
Relator claims that
Lincare used a “host of tricks” to generate false reports that
2
enabled the company to sell oxygen and other services to customers
who were unqualified to receive them.
Id. at ¶¶ 22, 25.
Relator alleges that each morning Lincare’s office manager,
Kay DeWeese, and licensed practical nurse, Dee Mason, would hold
a staff meeting in the Natchez office. Id. at ¶ 23.
During these
meetings, Lincare’s delivery employees were allegedly told to
instruct any potential customers receiving Virtuox machines to
utilize the machines in a manner that would generate a low arterial
oxygen saturation level. Id. Specifically, employees were taught
to direct patients:
(i) to ensure any pain medications or antihistamines are
taken before going to sleep; (ii) not to remove any fake
nails before going to sleep; (iii) to raise the arm to
which the sensor is attached while conducting the test;
and (iv) to de-elevate his or her head before going to
sleep.
Id. at ¶ 24.
Relator alleges that for customers who had already
been provided a positive airway pressure machine for sleep apnea
or other conditions, Lincare used a software system called Profox
to test the patient’s arterial oxygen saturation. Id. at ¶ 26.
These Profox tests were administered without physician approval,
and, as with the Virtuox machine, customers were instructed to
take the test in such a manner as to lower the arterial oxygen
saturation number. Id.
to
improperly
“qualify”
Lincare allegedly used these techniques
patients
for
Medicare-covered
oxygen
services. Id. After reporting this conduct to Lincare’s Compliance
3
office on two occasions, Relator claims he was terminated for
“insubordination” and “causing discord.” Id. at ¶ 27.
This
oximetry
testing
Lincare’s Natchez office.
scheme
allegedly
extended
beyond
Relator claims that two employees
stationed in other locations reported that Lincare improperly
coached patients to “use the Virtuox machine right after walking
up stairs . . . walk around the room while the Virtuox machine
[is] connected, [] hold their breath while using the machine. . .
or [] have a family member with a known low oxygen saturation to
wear the machine instead.” Id. at 29.
And another employee
allegedly reported that Lincare would deliver oxygen and equipment
to patients before obtaining physician approval. Id. at 32.
On February 25, 2015, Relator filed his original Complaint
against the defendant under seal, alleging that Lincare violated
Sections 3729(a)(1)(A), (B), and (G) of the FCA by submitting
fraudulent bills to the government after deliberately manipulating
and falsifying pulse oximetry tests to generate the appearance of
low oxygen saturation levels.
Id. at ¶ 37.
Relator also asserted
a claim for retaliatory discharge under Section 3730(h). The
Complaint was unsealed on August 24, 2015 after the government
declined
to
intervene.
Defendant
Lincare
moved
to
dismiss
Relator’s complaint for lack of subject matter jurisdiction and
failure to state a claim under Federal Rules of Civil Procedure
12(b)(1) and 12(b)(6).
4
II. Discussion
A. False Claims under 31 U.S.C. § 3729
Lincare urges the Court to dismiss the complaint under Rule
12(b)(1) for lack of subject matter jurisdiction because the FCA’s
first-to-file
bar
precludes
Relator’s
claims.
Additionally,
Lincare submits that dismissal for failure to state a claim under
Rule
12(b)(6)
insufficiently
disclosure
is
warranted
pled
bar.
because
and
precluded
When
also
a
Rule
Relator’s
12(b)(1)
by
the
motion
claims
FCA’s
is
are
public
filed
in
conjunction with a motion under Rule 12(b)(6), the Court considers
the
jurisdictional
challenge
5349153, *3 (N.D. Miss. 2013).
first.
Roop
v.
Melton,
2013
WL
Thus, the Court shall address the
jurisdictional challenge to Relator’s FCA claims under the firstto-file bar before considering Lincare’s arguments for dismissal
under Rule 12(b)(6).
1.
Subject Matter Jurisdiction
When considering a motion to dismiss under Rule 12(b)(1), the
Court may look to: “(1) the complaint alone, (2) the complaint
supplemented
complaint
by
undisputed
supplemented
by
facts
in
undisputed
the
record,
facts
plus
or
the
(3)
the
court’s
resolution of disputed facts.” U.S. ex rel. Colquitt v. Abbot
Laboratories, 864 F. Supp. 2d 499, 516 (N.D. Tex. 2012).
The Court
considers all well-pled allegations as true, viewing them in the
light most favorable to the plaintiff. Id.
5
The party asserting
jurisdiction bears the burden of proving that jurisdiction does in
fact exist. Ramming v. U.S., 281 F.3d 158, 161 (5th Cir. 2001).
The
FCA’s
first-to-file
bar
prohibits
plaintiffs
from
bringing “a related action based on the facts underlying [a]
pending action.” 31 U.S.C. § 3730(b)(5).
This jurisdictional bar
was enacted “to discourage opportunistic plaintiffs from filing
parasitic lawsuits that merely feed off previous disclosures of
fraud.”
F.3d
U.S. ex rel. Branch Consultants v. Allstate Ins. Co., 560
371,
376
(5th
Cir.
2009).
In
determining
whether
the
Relator’s claim is barred by the first-to-file provision, the court
must compare the relator’s complaint with the allegedly firstfiled complaint.
U.S. ex rel. Poteet v. Medtronic, Inc., 552 F.3d
503, 516 (6th Cir. 2009).
Though the allegations of fraud need
not
the
be
identical
across
lawsuits,
Section
3730(b)(5)’s
jurisdictional bar will apply “so long as the later-filed complaint
alleges the same material or essential elements of fraud described
in a pending qui tam action.” Id. at 378.
The first-to-file bar
enjoys relatively broad application, and the essential focus is on
“whether an investigation into the first claim would uncover the
same fraudulent activity alleged in the second claim.” U.S. v.
Planned Parenthood of Houston, 570 Fed. App’x 386, 389 (5th Cir.
2014). See also U.S. ex rel. Lujan v. Hughes Aircraft Co., 243
F.3d 1181, 1189 (9th Cir. 2001) (“once the government knows the
essential facts of a fraudulent scheme, it has enough information
6
to discover related frauds”).
Thus, a relator cannot avoid the
first-to-file bar by “simply adding factual details or geographic
locations to the essential or material elements of a fraud claim
brought against the same defendant” in a prior suit. Branch, 560
F.3d at 378.
In its motion, Lincare argues that Relator’s fraud claims are
precluded
by
the
FCA’s
first-to-file
bar
because
they
are
duplicative of allegations previously asserted in a case pending
before the United States District Court for the District of
Massachusetts. See U.S. ex rel. Robins et al. v. Lincare, Inc. et
al., 1:10-cv-12256-DPW (D. Mass. 2014).
Lincare contends that
because Relator alleges the same general conduct and theory of
fraud contained in the Robins complaint, Relator’s claims must be
dismissed. In response, Relator maintains that Robins is unrelated
to the fraudulent scheme alleged in this case, therefore the firstto-file bar should not apply.1
Comparing the Robins complaint with the complaint sub judice,
the
Court
finds
that
the
allegations
contained
therein
are
sufficiently related so as to preclude Relator’s claims under the
first-to-file
fraudulent
bar.
scheme
Robins
in
alleges
violation
of
that
the
Lincare
FCA
by
conducted
a
improperly
1 The parties do not dispute that Robins was filed prior to the instant
case, nor do they dispute that Robins is currently “pending” for purposes of
the first-to-file bar.
7
administering
pulse
oximetry
testing
without
approval
authorization:
Lincare generally engaged in . . . billing for
portable oxygen tanks when the customer did not
require them . . . [and] testing potential customers
and providing oxygen to Medicare beneficiaries
without physician orders. Robins Compl., ¶ 4.
Specifically, Lincare falsely and fraudulently billed
the government for services and equipment that were
non-reimbursable, were not medically necessary, . . .
or were provided in direct violation of the applicable
standards
and
regulations
governing
Lincare’s
provision of oxygen equipment and services. Robins
Compl., ¶ 3.
Lincare’s service representatives provide customers
with instruction and training regarding equipment use
and maintenance, as well as compliance with the
prescribed therapy. Robins Compl., ¶ 50.
Lincare routinely initiated and conducted oximetry
testing to discover new oxygen customers. Robins
Compl., ¶ 203.
Service representatives were given a pulse oximetry
overnight testing device and instructed, as part of
their daily routes, to provide it to the non-oxygen
customers and instruct the customers how to use the
device.
The
service
representatives
told
the
customers that a simple overnight test needed to be
performed as part of their treatment. Lincare service
representatives were trained to tell customers, when
they asked who had ordered the testing, that their
physicians had ordered it.
In fact, Lincare had
initiated the testing; the customer’s physician was
unaware that it was being conducted. Robins Compl., ¶
205.
If the results showed that a customer’s oxygen level
was low enough to justify oxygen therapy, the center’s
sales representative took the results to the
customer’s physician and tried to convince the
physician to prescribe oxygen. Robins Compl., ¶ 206.
8
or
Similarly, Count I of Relator’s complaint cites violations of 31
U.S.C. § 3729(a)(1), alleging:
[Lincare] has submitted and/or caused to be submitted
false or fraudulent claims to Medicare and Medicaid by
having non-qualified providers perform, participate
and/or instruct patients with regards to the pulse
oximetry test, deliberately manipulating and falsifying
pulse oximetry results to generate the appearance of low
oxygen saturation levels so that it could provide
Medicare-covered oxygen to patients that were not
qualified to receive it.
Compl., ¶ 37.
As in Robins, Relator alleges that Lincare violated
Medicare guidelines by delivering oximetry machines to prospective
customers’ homes, where unqualified delivery employees would then
instruct patients to use the machine. Compl., ¶ 22.
Relator also
claims that Lincare delivered oxygen and respiratory equipment to
prospective customers without physician approval, and for those
patients already receiving Lincare services, Lincare performed
unauthorized
saturation.
assessments
Id.
at
¶¶
of
26,
the
32.
patients’
After
arterial
allegedly
oxygen
instructing
customers to take the assessment in a manner that would lower the
arterial
oxygen
saturation
result,
Lincare
would
attempt
to
“upsell” customers by encouraging them to purchase oxygen or by
convincing the customers’ physician to prescribe oxygen. Id.
Relator disputes that the Robins scheme bears any similarity
to the fraudulent conduct forming the basis of his claims. Relator
argues that these fraudulent schemes are distinguishable because
Robins
fails
to
mention
that
Lincare
9
instructed
patients
to
manipulate oximetry tests to produce a qualifying result. Although
Relator offers additional facts about the manner in which Lincare
instructed customers to take the unauthorized oximetry tests,
these
additional
details
are
insufficient
to
save
Relator’s
claims. See Branch, 560 F.3d at 266 (relator could not avoid the
first-to-file bar by focusing on additional instances of fraud
occurring in different geographic locations); Planned Parenthood,
570 Fed. App’x at 390 (allegations that medical services were
performed but improperly coded were not sufficiently distinct from
earlier allegations that the defendant submitted bills for medical
services
not
performed);
U.S.
ex
rel.
Bane
v.
Life
Care
Diagnostics, 2008 WL 4853599 (M.D. Fla. Nov. 10, 2008) (barring
later filed suit despite slight variations in fraudulent scheme);
see also U.S. ex rel. Poteet v. Medtronic, Inc., 552 F.3d 503, 517
(6th
Cir.
2009)
(the
fact
that
allegations
covered
somewhat
different time periods was irrelevant where the complaints alleged
“the same type of fraudulent activity by the same general group of
actors”).
The fraudulent scheme depicted in Relator’s complaint is
largely based on the same underlying facts as the Robins scheme,
namely
that
Lincare
submitted
fraudulent
claims
by
issuing
oximetry tests without physician approval or authorization, that
Lincare administered these tests in an effort to qualify nonoxygen customers for Medicare covered oxygen, that unqualified
10
delivery personnel provided customers with instructions on how to
take these unauthorized oximetry tests, and that Lincare used these
test
results
to
influence
physicians
to
prescribe
oxygen
customers who were otherwise unqualified to receive it.
the
additional
facts
advanced
by
Relator,
i.e.
to
Further,
that
Lincare
manipulated the administration of oximetry tests, could not have
occurred but for the fact that Lincare administered the tests
without
authorization.
Based
on
the
substantial
overlap
in
material facts underlying these alleged schemes, the Court finds
that the complaints are sufficiently “related” for purposes of the
first-to-file
bar.
Both
complaints
essentially
allege
that
Lincare violated the FCA by generating false reports and performing
unauthorized
patients
for
assessments
in
an
Medicare-covered
effort
oxygen.
to
The
improperly
Robins
qualify
complaint
contains broad allegations of multiple schemes and extensive,
wide-reaching fraud orchestrated by defendant Lincare.
Compl., ¶¶ 25, 65, 89.
Robins
With allegations of Lincare’s nationwide
fraudulent scheme, Robins provided sufficient information to put
the government on notice of the related fraud described here, as
it is likely that an investigation into the Robins allegations
would
reveal
complaint.
the
fraudulent
conduct
alleged
in
Relator’s
Accordingly, the Court finds that Relator’s FCA claims
under § 3729 are precluded by the first-to-file bar and shall
therefore be dismissed without prejudice. See U.S. ex rel. Chovanec
11
v. Apria Healthcare Group Inc., 606 F.3d 361 (7th Cir. 2010)
(dismissal based on § 3730(b)(5) should be without prejudice
because the first-to-file bar only applies while the initial
complaint is “pending”).
2. Failure to State a Claim
Even
assuming
jurisdictionally
that
barred,
the
Count
Relator’s
I
of
the
FCA
claims
Complaint
are
should
not
be
dismissed based on the insufficiency of Relator’s allegations in
light of the pleading standards governing Rule 8, Rule 9, and Rule
12(b)(6). Lincare moves for dismissal under Rule 12(b)(6), arguing
that Relator’s claims are insufficient to state a claim under the
FCA.
Under Rule 12(b)(6), a court may dismiss a suit for “failure
to state a claim upon which relief can be granted.” Fed. R. Civ.
P. 12(b)(6).
Pleadings must contain a “short and plain statement
of the claim” showing the plaintiff is entitled to relief. Fed. R.
Civ. P. 8(a)(2). To survive a motion for dismissal under Rule
12(b)(6), the plaintiff must plead “enough facts to state a claim
to relief that is plausible on its face.” U.S. ex rel. Rafizadeh
v. Continental Common, Inc., 553 F.3d 869, 872 (5th Cir. 2008).
“A claim has facial plausibility when the plaintiff pleads factual
content that allows the court to draw the reasonable inference
that the defendant is liable for the misconduct alleged.” Ashcroft
v. Iqbal, 556 U.S. 662, 678 (2009).
12
In considering the motion,
the “[C]ourt accepts all well-pleaded facts as true, viewing them
in the light most favorable to the plaintiff.” Martin K. Eby Const.
Co., Inc. v. Dallas Area Rapid Transit, 369 F.3d 464, 467 (5th
Cir. 2004).
In
addition
to
satisfying
the
plausibility
requirement
articulated in Iqbal, claims brought under the FCA must also comply
with the supplemental pleading standards of Rule 9(b). U.S. ex
rel. Steury v. Cardinal Health, Inc., 735 F.3d 202, 204 (5th Cir.
2013); U.S. ex rel. Grubbs v. Kanneganti, 565 F.3d 180, 190 (5th
Cir. 2009) (“Rule 9(b) supplements but does not supplant Rule
8(a)’s notice pleading.”).
Rule 9 works to “weed out meritless
fraud claims sooner rather than later,” and the Fifth Circuit
applies the rule to FCA claims “with ‘bite’ and ‘without apology.’”
Grubbs, 565 F.3d at 185. Rule 9 requires that “in alleging fraud
or mistake a party must state with particularity the circumstances
constituting fraud or mistake.”
Fed. R. Civ. P. 9(b).
At a
minimum, the plaintiff must set forth the “who, what, when, where,
and how of the alleged fraud.”
Steury, 735 F.3d at 204.
Applying this standard, the Court finds that Relator has
failed
to
sufficiently
required by Rule 9(b).
allege
fraud
with
the
particularity
In Count I of the complaint, Relator
alleges claims under Section 3729(a)(1), which imposes liability
on any person who:
13
(A) knowingly presents, or causes to be presented, a
false or fraudulent claim for payment or approval;
(B) knowingly makes, uses, or causes to be made or used,
a false record or statement material to a false or
fraudulent claim; [or]
. . . .
(G) knowingly makes, uses, or causes to be made or used,
a false record or statement material to an obligation to
pay or transmit money or property to the Government, or
knowingly conceals or knowingly and improperly avoids or
decreases an obligation to pay or transmit money or
property to the Government . . .
31 U.S.C. § 3729(a)(1).
To state a claim under the FCA, plaintiffs
must allege: “(1) a false statement or fraudulent course of
conduct; (2) made or carried out with the requisite scienter; (3)
that was material; and (4) that caused the government to pay out
money or forfeit moneys due (i.e. that involved a claim).” U.S. ex
rel. Longhi v. United States, 575 F.3d 458, 467 (5th Cir. 2009);
Steury, 735 F.3d at 267.
Relator’s FCA claims are fatally flawed because the complaint
fails to sufficiently allege the presentment of a claim.
The
linchpin of an FCA claim is the “false claim.” U.S. ex rel.
Rafizadeh v. Continental Common, Inc., 553 F.3d 869 (5th Cir.
2008); U.S. ex rel. Parikh v. Brown, 587 Fed. App’x 123, 128 (5th
Cir. 2014) (“[FCA] attaches liability . . . to the claim for
payment, not to the underlying fraudulent activity.”); U.S. ex
rel. Phillips v. Pediatric Services of America, Inc., 142 F. Supp.
2d 717, 730 (W.D.N.C. 2001) (“a central question in False Claims
14
Act cases is whether the defendant ever presented a false or
fraudulent claim to the government”).
To survive dismissal, the
Fifth Circuit has held that relators must, at a minimum, plead the
“particular details of a scheme to submit false claims paired with
reliable indicia that lead to a strong inference that claims were
actually submitted.” U.S. ex rel. Grubbs v. Kanneganti, 565 F.3d
180,
190
(5th
Cir.
2009)
(reversing
dismissal
of
relator’s
complaint, which contained “dates and descriptions of recorded,
but un-provided services, and a description of the billing systems
that records were likely entered into”).
Here, Relator’s complaint falls short of the standard set
forth in Grubbs.
The complaint contains no reference to financial
statements evidencing any claim, nor does Relator allege any
identifying information about the amount of specific claims or the
dates on which they were submitted. Relator’s complaint also lacks
the requisite indicia of the specific scheme to submit false
claims.
Relator
representative.
was
employed
by
the
defendant
as
a
sales
He provides no information about the company’s
billing system or other facts to suggest that he has knowledge of
how bills were submitted by Lincare for payment.
Relator alleges
that Ms. Mason and Ms. DeWeese instructed delivery personnel to
improperly coach patients, but the complaint fails to identify any
delivery personnel who complied with these instructions or any
billing
personnel
who
submitted
15
false
claims
as
a
result.
Furthermore, Relator fails to identify which, if any, of the
oximetry tests administered during Relator’s employment produced
false results, who recorded those false results, or how Lincare
fraudulently certified its compliance with Medicare regulations in
order to effect payment.
Relator assumes that Lincare submitted false claims at some
point in time simply because delivery personnel were instructed to
administer oximetry tests incorrectly.
But the relator is not
permitted “merely to describe a private scheme in detail but then
allege simply and without any stated reason for his belief that
claims requesting illegal payments must have been submitted, were
likely submitted or should have been submitted to the government.”
U.S. ex rel. Clausen v. Laboratory Corp. of America, Inc., 290
F.3d 1301, 1311 (11th Cir. 2002); see U.S. v. ex rel. Thompson v.
Columbia/HCA Healthcare Corp., 125 F.3d 899, 903 (5th Cir. 1997)
(“even where allegations are based on information and belief, the
complaint must set forth a factual basis for such belief”); U.S.
ex rel. Church v. Miss. Baptist Healthy Sys., Inc., 2005 WL
2375161, *4 (S.D. Miss. Sept. 26, 2005) (“latitude should only be
granted to a Relator when the pleadings set forth a factual basis
to substantiate their belief that fraud has occurred”); see also
U.S. ex rel. Nunnally v. West Calcasieu Cameron Hosp., 519 Fed.
App’x 890, 895 (5th Cir. 2013) (unpublished) (“the contents of a
false claim need not always be presented,” but this does not
16
relieve relators of the burden of satisfying the particularity
requirements of Rule 9).
At best, Relator’s complaint alleges a
general “scheme” by which false claims could have eventually been
submitted by Lincare.
vague
allegations
But despite the complaint’s general and
referencing
the
possibility
that
Lincare
submitted false claims, there is no specificity regarding who,
what, when, where, and how such alleged claims were submitted.
Because the complaint fails to provide some indicia of reliability
creating
a
strong
inference
that
false
claims
were
actually
submitted through the alleged scheme, Relator’s FCA claims are
subject to dismissal.
Additionally, Relator’s claim under the FCA’s reverse false
claims provision is deficient because the complaint fails to
mention any financial obligation Lincare may have owed to the
Government.
Liability under Section 3729(a)(1)(G) arises when a
defendant knowingly makes a false record or statement to avoid an
obligation
to
3729(a)(1)(G).
pay
money
to
the
Government.
See
31
U.S.C.
§
Claims under this provision require: “(1) that the
defendant had an obligation to pay money to the government, (2)
that the defendant used a false statement to avoid or decrease
that obligation, (3) that the false statement was material, and
(4) that the defendant made the false statement knowingly.” U.S.
ex rel. Branch Consultants, L.L.C. v. Allstate Ins. Co., 668 F.
Supp. 2d 780, 811 (E.D. La. 2009).
17
“Where a complaint ‘makes no
mention of any financial obligation that the [defendants] owed to
the government,’ and ‘does not specifically reference any false
records or statements used to decrease . . . an obligation,’ the
court should dismiss the subsection (a)(1)(G) claim.” U.S. v. ex
rel. Kester v. Novartis Pharm. Corp., 43 F. Supp. 3d 332, 368
(S.D.N.Y. 2014) (citing Wood ex rel. U.S. v. Applied Research
Assocs., Inc. 328 Fed. App’x 744, 748 (2d Cir. 2009); see Branch,
668 F. Supp. 2d at 811 (dismissing reverse false claims where
relator failed to identify any obligation owed by defendants).
Apart
from
citing
the
statutory
language
of
subsection
(a)(1)(G), Relator has not identified any monetary obligation owed
by defendant Lincare.
In his response to the motion, Relator
attempts to argue that Lincare violated the reverse false claims
provision by receiving a windfall which should have been refunded
to the government for government funded services.
But this
argument amounts to mere speculation as it is unsupported by the
factual allegations in the complaint.
Accordingly, Relator has
failed to adequately plead a violation of Section 3279(a)(1)(G).
The Court finds that Relator’s FCA claims under Count I are
precluded by the first-to-file bar.
Moreover, Relator has failed
to adequately plead his FCA claims in accordance with Rules 8, 9,
and 12(b)(6).
Because dismissal is warranted on these grounds,
the Court finds it unnecessary to determine whether the public
disclosure bar also precludes Relator’s claims.
18
B. Retaliation
In Count II of the complaint, Relator alleges retaliatory
discharge under 31 U.S.C. 3730(h).
employer
from
“discharging
.
.
Section 3730(h) prohibits an
.
or
in
any
other
manner
discriminating against an employee in the terms and conditions of
employment
because
of
lawful
acts
done
by
the
employee
furtherance of an action under the FCA.” Compl., ¶ 42.
in
Unlike
Relator’s other FCA claims, retaliation claims under 31 U.S.C. §
3730(h) need only satisfy the basic pleading requirements of Rule
8.
Guerrero v. Total Renal Care, Inc., 2012 WL 899228, at *3 (W.D.
Tex. March 12, 2012).
To bring an FCA retaliation claim, the
plaintiff must plead: (1) that he engaged in a protected activity;
(2) that his employer knew he was engaged in a protected activity;
and (3) that he was discharged because of it. Robertson v. Bell
Helicopter Textron, Inc., 32 F.3d 948, 951 (5th Cir. 1994).
To engage in a protected activity under the FCA, an employee’s
actions must be aimed at matters that “reasonably could lead to a
viable claim under the [FCA].” U.S. ex rel. Wuestenhoefer v.
Jefferson, 105 F. Supp. 3d 641, 676 (N.D. Miss. 2015) (“an employee
need not have filed an FCA lawsuit or have developed a winning
claim at the time of the alleged retaliation”); but see Hoyte v.
Am. Nat’l Red Cross, 518 F.3d 61, 68 (D.C. Cir. 2008) (employee’s
investigation
into
employer’s
noncompliance
regulations was not a protected activity).
19
with
federal
Internal complaints
are considered protected activity under the FCA if they “concern
false
or
fraudulent
claims
for
payment
submitted
to
the
government.” U.S. ex rel. George v. Boston Scientific Corp., 864
F. Supp. 2d 597, 604 (S.D. Tex. 2012) (no “magic words” are
required, but employee must state that he is concerned about
possible fraud in order to impute knowledge on the employer).
As
to the causal-link element of the prima facie case, “the showing
. . . is not onerous; the plaintiff merely has to prove that the
protected activity and the negative employment action are not
completely unrelated.” Id. at 609.
Here, Relator alleges that he reported the “illegal conduct”
to his superiors on two occasions and that he was “discharged by
the Defendant as a direct result of his acts” immediately after
the second occasion. Compl., ¶ 27, 34, 35.
Based on the facts
alleged, the Court finds that Relator’s allegations are sufficient
to state a plausible claim for retaliation and declines to dismiss
Count II on this basis.
C. Relator’s Identity
Although Relator’s retaliation claim survives the motion to
dismiss, Relator must disclose his identity in order to proceed
with his remaining claim. As Lincare aptly noted in its memorandum
in support of the motion to dismiss, Relator’s identity remains
undisclosed despite the fact that this case has been unsealed.
To
this point, the Government filed a Statement of Interest in the
20
case, arguing that Relator should no longer be permitted to proceed
as a John Doe plaintiff.
Finding no circumstances justifying
anonymity, the Court agrees.
Rule 10(a) requires that the names of all parties be included
in the complaint. Fed. R. Civ. P. 10(a). Consistent with the
general proposition that judicial proceedings should be conducted
in the open, courts have disfavored plaintiffs’ attempts to proceed
anonymously as “John Does.” See Southern Methodist Univ. Ass’n of
Woman Law Students v. Wynne & Jaffe, 599 F.2d 707, 712-13 (5th
Cir. 1979) (finding that plaintiffs have no right to proceed
anonymously absent special circumstances).
Generally, a plaintiff
may not proceed anonymously unless he can demonstrate a substantial
privacy right that outweighs the customary presumption of openness
in judicial proceedings. See Doe v. Hallock, 119 F.R.D. 640, 643
(S.D. Miss. Dec. 8, 1987); Doe v. Frank, 951 F.2d 320, 324 (11th
Cir. 1992) (anonymity is only appropriate in exceptional cases of
“highly sensitive and personal nature ... the risk that a plaintiff
may suffer some embarrassment is not enough”). The same principles
that disfavor John Doe plaintiffs in other cases apply equally to
qui tam matters. See U.S. ex rel. McLain v. Flour Enterprises,
2013 WL 4721367, at *1 (E.D. La. Sept. 3, 2013) (ordering John Doe
relators to identify themselves in an amended complaint or face
dismissal).
21
Relator has cited no facts, circumstances, or legal authority
which would allow him to proceed as a John Doe in this case.
Therefore, the Court finds that Relator must disclose his identity
or face dismissal as to his retaliation claim.
III. Conclusion
For the reasons set forth herein, Lincare’s motion to dismiss
is granted as to Relator’s FCA claims under Count I, but the motion
is denied as to Relator’s claim for retaliation under Count II.
Within ten (10) days of the entry of this Order, Relator shall
amend his complaint to identify himself in accordance with Rule
10.
Relator is hereby notified that failure to disclose his
identity through an amendment shall result in the dismissal of his
remaining claim.
Accordingly,
IT IS HEREBY ORDERED AND ADJUDGED that Lincare’s Motion to
Dismiss (docket entry 15) is GRANTED IN PART and DENIED IN PART.
FURTHER
ORDERED
that
Count
I
of
Relator’s
Complaint
is
DISMISSED WITHOUT PREJUDICE;
FURTHER ORDERED that Relator shall identify himself through
an amended complaint within ten (10) days of the entry of this
Order.
22
SO ORDERED this the 27th day of February, 2017.
/s/ David Bramlette
UNITED STATES DISTRICT JUDGE
23
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?